FDA advances plan allowing pharmacies to compound peptide drugs
The FDA is moving forward with a policy change that would temporarily allow specialty pharmacies to produce certain peptides, a class of largely unregulated injections favored by HHS Secretary Robert F. Kennedy Jr.
